chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was feeling lightheaded immediately following the HAVRIX vaccine. I instructed him to remain seated, a few moments later, he lost conciousness and passed out in the chair. My technician and I sat him upright and checked for breathing and no obstruction. 911 was immediately called and the paramedics arrived in under 5 minutes. EMT's took patient's vital signs and were within normal range. EMT's asked if he had used any drugs or alcohol today, patient responded that "he had a pint after work" EMS recommended and offered to take him to the emergency room, the patient declined treatment against medical advice. Patient remained in the pharmacy waiting area for approximately 30 minutes before leaving with his wife/girlfriend.
Appeared at office on 2/7/07 with rash on face, legs, moving to lower trunk, rash red and raised, site of injection red and swollen.
chills; muscle and joint pain; muscle and joint pain; tiredness; This is a spontaneous report from a contactable consumer or other non hcp.   A male patient of 60-year-old received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: ER8729), dose 1 via an unspecified route of administration on 15Apr2021 as dose 1, single for covid-19 immunization. Medical history included hernia repair, prostatomegaly from an, neck surgery. On an unspecified indication patient had Concomitant medication(s) included hydromorphone hydrochloride (DILAUDID) taken for pain; oxycodone hydrochloride, paracetamol (PERCOCET [OXYCODONE HYDROCHLORIDE;PARACETAMOL]); terazosin; finasteride (PROSCAR); nortriptyline; lubiprostone taken for an unspecified indication, start and stop date were not reported; ketorolac; omeprazole; pregabalin (LYRICA); paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported; tizanidine hydrochloride (ZANAFLEX) as start and stop date were not reported. On an unspecified date, patient experienced chills, muscle and joint pain, muscle and joint pain, tiredness. The outcome reported was unknown. No follow up attempts are possible. No further information is expected.
per death certificate, one of the causes of death was acute encephalopathy with COVID 19 viral infection; faxed for med records from Dr. who signed the death certificate, but never received records; death certificate sent to info@vaers.org per VAERS request
Patient was administered an MMR vaccine which had been expired for 4 days. Date of administration 4-14-2020, expiration date on vaccine 4-10-2020.  Also called the manufacturer, Merck, spoke to staff. Staff stated that the vaccine still should have enough potency & that the patient should not need an additional dose unless the provider thought otherwise. The provider also believes that the vaccine that was administered should be good given the fact that it was only 4 days expired. The patient's mother was informed of the situation and states that her daughter is perfectly fine and did not experience any adverse reactions what-so-ever.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concurrent medical conditions included Sinusitis.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). At the time of the report, VACCINATION SITE PAIN (Sore arm) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment Medications includes Cefomex 5 pills, for sinusitis   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Updated the Patient demographic details.Updated the second dose information.Updated the outcome of the event sore arm from recovering to Recovered/Resolved. Patient denied further follow up.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported event, a causal relationship cannot be excluded.
My son had 103.5 fever for 3 days. I called their office multiple times and they told me this was normal. Starting crying in extreme pain for hours. My son was completely normal before this vaccine. 3 days after this vaccine it was like a light switched off in his brain. He no longer speaks, no eye contact, hides in corners and is now in therapy 4 days a week. He doesn't respond to me calling his name anymore and for 5 months after this wouldn't even allow me to hold him anymore.
Moderna COVID-19 Vaccine EUA Mild headache/eye aches, vertigo, no elevated body temp. Eight days after injection got a large, splotchy rash around injection site. At nine days the rash turned into a 2"x4" hive with various hive around it on my shoulder and neck.
BODY ACHES; DULL HEADACHE; FEVER; HEAD CONGESTION WORSENED; This spontaneous report received from a patient concerned a 55 year old female. The patient's weight was 147 pounds, and height was 67 inches. The patient's past medical history included hyperthyroidism, and concurrent conditions included allergic to chocolate and caffeine, head congestion, migraines, and allergic to some antibiotics. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, and expiry: UNKNOWN) dose was not reported, administered on 25-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 25-JUN-2021, the subject experienced body aches. On 25-JUN-2021, the subject experienced dull headache. On 25-JUN-2021, the subject experienced fever. On 25-JUN-2021, the subject experienced head congestion worsened. Laboratory data included: Body temperature (NR: not provided) 99 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from body aches, dull headache, fever, and head congestion worsened. This report was non-serious.
My middle finger of the arm that was vaccinated began to hurt and stiffen up. I was unable to bend my finger at the top knuckle without pain. This lasted for 2 days.
Headache, Myalgia, chills required treatment with topical "biofreeze", acetaminophen 650mg and ibuprofen 400mg
cardiac arrest; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A 24-year-old patient received BNT162b2 (COMIRNATY), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CARDIAC ARREST (medically significant), outcome "unknown".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
09mar90 pt vax 3rd hepta B. 14mar90 pt devel blotchy areas on chest, lip and forehead, itching at base of skull and neck.  pt treated w pres drug therapy. 2weeks later pt devel hives.
Initial information received on 27-Jul-2018 regarding an unsolicited valid non-serious case received from a nurse. This case involves 2 month old male patient who was vaccinated with 0.5 ml (batch number U6002AA, expiry date 11-SEP-2019 and site of administration were not reported) intramuscularly on an unspecified date instead of PREVNAR. Patient concurrently received PENTACEL for Immunisation for Immunisation; ENGERIX for Immunisation; and ROTATEQ for Immunisation. It was a case of actual medication error as Wrong vaccine administered. There are no reported reactions/symptoms. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Documents held by sender: none.
5/3/2022 I started having a scratchy throat which developed into COVID systems. I had brain pressure, sinus and chest congestion and a hacking nonproductive dry cough. I was extremely tired but could not sleep more than 4 hours at a time. On 5/9/2022 I was sleeping 2-4 hours of sleep at a time but sleeping a lot. I was not mentally clear. I would have been afraid to drive. I felt like I could fall while walking. Even though I am retired but go in one day a week to work but have been unable to go into work so far. I still have a little bit of brain fog, but can drive and walk now.
SWOLLEN, PAINFUL FEET; RED PATCHES OVER MY BODY; LOOKS LIKE VARICOSE VEINS IN FEET; LEGS FEEL STRANGE FROM KNEES DOWN; CAN NOT SLEEP LONG AT A TIME; FEEL LIKE HELL; CAN NOT STAND ON FEET BUT A FEW MINUTES AT A TIME; CAN NOT DO HOUSEWORK; SLEEPY ALL DAY LONG; PANICKED; BUTT GOES TO SLEEP; WEAK; This spontaneous report received from a patient via a company representative via social media concerned a patient of unspecified age, sex, and ethnic origin. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had no family history of varicose veins. The patient was previously treated with covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (dose number in series 1) (suspension for injection, route of administration was not reported, batch number: Unknown and expiry: Unknown) dose, start therapy date were not reported, 01 total administered for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s (dose number in series 1). The patient additionally received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of administration was not reported, batch number: Unknown and expiry: Unknown) dose, start therapy date were not reported, 01 total administered for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced swollen, painful feet, red patches over my body, looks like varicose veins in feet, legs feel strange from knees down, can not sleep long at a time, feel like hell, can not stand on feet but a few minutes at a time, can not do housework, sleepy all day long, panicked, butt goes to sleep, and weak (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the swollen, painful feet, red patches over my body, looks like varicose veins in feet, legs feel strange from knees down, can not sleep long at a time, feel like hell, weak, can not stand on feet but a few minutes at a time, can not do housework, sleepy all day long, panicked and butt goes to sleep was not reported. This report was non-serious.
Arm pain Fatigue Left axillary lymph node enlarged and tender Muscle tightness to left upper chest wall
Tingle to face started about 4 hours after dose, was ongoing a few hours then off and in for 1-2 days. Extremely tired with brain fog started evening of second shot and has been ongoing. Just starting to improve after 4 weeks.
I got a rash 10 days after my vaccine.  Hives all over, itching that would come and go that was unbearable.  No history of any allergies ever and never had any skin conditions.  Generally perfectly healthy.  As of 33 days since I first got it, I am still experiencing bouts of rashs.  If it flares up and I scratch, it will leave long scratch marks on my back like Dermatopgraphia.  My situation was also complicatedbythe fact that I tested positive for COVID-19 6 days after my booster shot.  Booster on Dec 10th, Dec 16th Test Positive, Dec 20th rash/hives start.
Immediate symptoms cold sweat, "woosy", pale.  Gait affected, slurred speech.
For the next two hours my chest felt tight and a little hard to breathe. My tongue felt tingling.As the day passed, the side effects were less. The next day I felt normal
Did a home test on 06/16/2022, it was positive, went to my doctor 06/17/2022, tested positive, was given the anti-virals, on 4th day developed a sore spot on my ankle like I get when I take Sulfa drugs. The spot went away after I stopped the anti-viral. COVID_19 symptoms of fever, lethargy, sore throat, achy.
08/25/222 Patient called clinic describing  he was having  increase swelling, redness, itching, and pain in the injection site. RN advice patient  to go to PCP or urgent care/ emergency room for further evaluation.   08/26/2022 RN called patient for follow-up. Patient stated he was evaluated by his PCP and was given antihistamine, corticosteroid cream and antibiotics for possible allergic reaction to the vaccine.  Patient inform to ask PCP if able to receives Jynneos vaccine in the future and when receiving vaccines in the future to inform staff of his reaction to the Jynneos vaccine. Patient verbalized understanding.
Patient received Bivalent vaccine as first dose of primary series by accident. No adverse event/effect followed.
Lymphadenopathy followed by monoclonal B cell lymphocytosis active two months after dose
Taken to hosp. due to seizures etiology unknown. Referred to MD (neurology). Child continue with mini seizures. 60-day follow up on 11/21/2003: "Vaccine recipient did not recover from the adverse events that were reported for this vaccination.  10/29/2003 AM: Nurse left message.  10/29/2003 PM: Continues with seizures and asthma (seizure disorder-epilepsy unspecified.  Being seen by neurologist." Annual follow up on 04/20/04: "Pt has not recovered from adverse events.  Telephone call to RN as recently as 03/08/04, child still had seizure diagnosis of seizure disorder." Follow up on 5/19/04: Telephone call to pt's mother. Phone number no longer works. Telephone call to nurse, left message. Child has seizure disorders.
This spontaneous case, initially received on 02-Nov-2016, was reported by a health professional and concerns a 54 year old patient. Weight: not provided; Height: not provided. Concomitant medication: Not reported. Administration of company suspect drug(s): On 16-Sep-2016 the patient received AFLURIA. Dose regimen: Not reported, Route of administration: Intramuscular. Batch number: WT54306. No additional suspect drugs. Adverse event description: On 23-Sep-2016, a nurse reported that a refrigerator went in and out of (temperature) range while there was flu vaccine in it. On 16-Sep-2016, doses were administered (special circumstances: drug administration error without adverse event, incorrect product storage without adverse event). Flu vaccine was first delivered to the vaccination facility on 15-Aug-2016. As the nurse reviewed the refrigerator temperature log, she stated that another excursion occurred on 15-Sep-2016. The doses arrived at 09:00 and were placed in a refrigerator that was at 10 degrees Celsius in the morning. Then the temperature remained at 9 degrees Celsius throughout the 15th and 51 doses were administered on the 16th at a flu clinic. The refrigerator was not back in range until 19-Sep-2016 at a temperature of 8 degrees Celsius. Temperature excursion identified: Log documentation reflected temperature excursions from 31-May-2016 to 23-Sep-2016 which ranged between 8 to 10 degrees Celsius. Vaccines had been given to patients between 31-May-2016 to 23-Sep-2016. On 04-Oct-2016, the remaining 42 doses of lot number WT54306 were discarded. The patients will be contacted for revaccination.
Sxs started in about 4 hours - itching and rash, head to toe. No shortness of breath or difficulty breathing.
pt recvd flu vax & pt devel a wheal, accompanied by swelling, pain & heat;
Patient started on amoxicillin prior to arrival at ED. Complaints on itching to multiple parts of body, starting with scalp and ears. Patient arrived 3/7/21 in ED with these complaints but received moderna 2/10/21. Treatment include benadryl and steroids. Based on visit to ED patient may have had a reaction to antibiotics rather than moderna from 2/10/21.
light headed; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (light headed) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced DIZZINESS (light headed). At the time of the report, DIZZINESS (light headed) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.
Per mother's report, child began to exhibit a red, pinpoint rash on abdomen on 3/14/18, which then spread to whole abdomen, back and head. Child also had local redness and swelling on left thigh that started on 3/11/18, which has persisted - but is within a normal expected reaction. Child was evaluated on 3/21/18 at the ER - with the diagnosis of viral rash and cellulitis of left leg. Child was prescribed Cephalexin 250 mg/5 ml suspension - 4.6 ml PO twice daily for 10 days, Mupirocin 2% ointment three times daily, thin layer on thigh redness. Mother also reported a low grade fever and general less appetite for the child in the past few days, which she believes is related to tooth eruption. Mother was told to be seen in 5 days if for a follow-up visit at the medical home.
Patient was administer 0.3 mL of undiluted Pfizer Vaccine.  Pt. offered MD exam to include EKG and troponin levels with follow up Pt complains of migraines
330 p.m. on day one after vaccines developed fever of 103, chills, body aches. This lasted for 18 hours.
Passed out; This is a spontaneous report from a contactable other Health Care Professional. A 69-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6204 and Expiry date: 30Jun2021), dose 2 via an unspecified route of administration, administered in Arm Left on 10Mar2021 13:45 (at the age of 69-years-old) as DOSE 2, SINGLE for Covid-19 immunization. Medical history included ongoing diabetes mellitus Verbatim: type two diabetes, breast cancer from an unknown date and unknown if ongoing Verbatim: Breast cancer. She had breast cancer 11 years ago and Taxotere dropped her blood pressure till she collapsed on the floor and came close to passing out, she went down like a rock, this was back in 2010. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. The patient received other medications of vaccination. The patient was not diagnosed with Covid 19 and has not been tested for Covid-19 Since the vaccination. Concomitant medication included metformin taken for an unspecified indication, start and stop date were not reported. The patient previously took Taxotere, bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) on 17Feb2021 at 18:30 for Covid-19 immunization and her arm was fine and did not really get sore. She had no reaction to the first dose it was just a poke in the arm and all was well. On 12Mar2021 the patient passed out. She passed out 45 hours after the second dose. She hit the edge of a chair in the bathroom. She went to the emergency room, she got 4 stitches since it tore the flesh off her left ear to point that cartilage could be seen. She has one doctor saying to get the booster and one doctor saying not to get the booster. She wants the booster and does not have an objection to it but does not want to end up in the ER. At the time she went to ER she explained to the doctor that the same thing happened when she had the medication Taxotere in 2010 and the ER doctor told her she is not blaming Pfizer for this and states she is not blaming anything. She was told later by the infusion center where she would get her port flushed, that there was something that begins with a T acid that is in taxotere and the covid vaccine, states if she puts two and two together, they both have that t acid ingredient in them. The outcome of event was unknown.; Sender's Comments: Based on the limited information in the case, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported Loss of conciousness. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Flushing/sweating, tingling, numbness. BP 162/97 (pulse 89), O2 sat 99%. Benadryl 25 mg PO given.
Injection site pain tenderness and swelling. Fatigue, headache, muscle pain, joint pain, chills, fever, night sweats,  lethargy. Lasting two days
I tested positive for COVID on Jan 21 2021. My symptoms were generally mild - loss of taste and smell, fatigue, some chest tightness (seemed like allergies until the taste and smell disappearred). As of today, taste and smell are still not normal (anosmia shifted to parosmia). Immediately following both vaccinations, 'standard' reported side effects were very mild - mild arm pain, fatigue, but no fever, achiness, etc. However, about a week after the first vax, i started to descend into a neurological haze - brain fog, muscle weakness/nerve issues (particularly in the face (mouth/eyes), neck, hands (challenges with grasp, tingly/numbness), legs (heavy, less muscle control upon standing). In that week after the first
Information has been received from a nurse concerning a patient who was vaccinated with a 0.5 ml dose of Pneumovax 23 (lot # 654982/0675F).  Subsequently the patient experienced severe localized reactions which included welts and a rash on the extremity that was vaccinated, but not necessarily at the injection site.  The reaction was reported "from the shoulder to the elbow."  The patient sought unspecified medical attention.  It was reported that the lot # would not be used and there was concern expressed regarding the lot number.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot met the requirements of the agency and was released by the regulatory agency.  Additional information has been requested.
Patient states feeling lightheaded, hot, and nauseous while waiting 15 minutes at the waiting area post vaccination. Upon being assessed by EMS, patient did vomit.
Donor stated as soon as she received tetanus she felt tighten in arm, nauseated, blurred vision, near syncope. Tech not alerted. Upon getting payment Donor c/o lightheadedness. Admits to minimal hydration for past 24 hrs. Donor provided oral fluids 16 ox water, 14 oz juice Eval 25 mins - CP called immediately on need for VAERS. No per CP Donor w/o symptoms and Departure. BP 98/64 HR 68 T.O, pending CP review